share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Apr 3 16:39
Summary by Futu AI
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月3日期間，通過上海證券交易所回購共計7,002,957股A股股份，佔公司於回購前已發行股份的約0.28%。該公司股份回購的價格範圍介於RMB 46.84至RMB 57.32之間。最新一次回購發生於2024年4月3日，當日回購股份數目為423,291股，每股價格介於RMB 46.84至RMB 47.86，總金額為RMB 20,049,121.68。根據香港聯合交易所有限公司證券上市規則，公司已於2024年4月3日向香港聯交所提交翌日披露報表，確認股份回購活動已獲董事會批准，並符合所有相關法律規定。
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月3日期間，通過上海證券交易所回購共計7,002,957股A股股份，佔公司於回購前已發行股份的約0.28%。該公司股份回購的價格範圍介於RMB 46.84至RMB 57.32之間。最新一次回購發生於2024年4月3日，當日回購股份數目為423,291股，每股價格介於RMB 46.84至RMB 47.86，總金額為RMB 20,049,121.68。根據香港聯合交易所有限公司證券上市規則，公司已於2024年4月3日向香港聯交所提交翌日披露報表，確認股份回購活動已獲董事會批准，並符合所有相關法律規定。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased a total of 7,002,957 shares A shares through the Shanghai Stock Exchange between March 8 and April 3, 2024, representing approximately 0.28% of the company's shares issued prior to the repurchase. The price range for the share repurchase of the company ranges from RMB 46.84 to RMB 57.32. The most recent repurchase took place on April 3, 2024. The number of shares repurchased on that date was 423,291 shares at a price of RMB 46.84 to RMB 47.86 for a total amount of RMB 20,049,121.68. Pursuant to the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company filed a Next Day Disclosure Statement with the HKEX on 3 April 2024 confirming that the share repurchase has been approved by the Board of Directors and complies with all relevant legal requirements.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased a total of 7,002,957 shares A shares through the Shanghai Stock Exchange between March 8 and April 3, 2024, representing approximately 0.28% of the company's shares issued prior to the repurchase. The price range for the share repurchase of the company ranges from RMB 46.84 to RMB 57.32. The most recent repurchase took place on April 3, 2024. The number of shares repurchased on that date was 423,291 shares at a price of RMB 46.84 to RMB 47.86 for a total amount of RMB 20,049,121.68. Pursuant to the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company filed a Next Day Disclosure Statement with the HKEX on 3 April 2024 confirming that the share repurchase has been approved by the Board of Directors and complies with all relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.